Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8534

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 0615-8534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rosuvastatin Aurobindo 1)

Chemical Structure (Rosuvastatin Aurobindo 1)
Chemical structure of Rosuvastatin Calcium, depicted with its molecular components including aromatic rings, hydroxyl groups, and calcium ion coordination, representing the active ingredient of the prescription drug Rosuvastatin Calcium.*
FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Aurobindo 2)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Aurobindo 2)
A cumulative incidence graph comparing Rosuvastatin Calcium (Rosuva) and placebo over approximately 5 years. The y-axis shows cumulative incidence percentage, and the x-axis shows years. The graph includes a hazard ratio with confidence interval and significance level. Number at risk data is shown below the graph for both groups.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Aurobindo 3)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Aurobindo 3)
A data table displaying the number of events, hazard ratios (HR), and p values comparing Rosuvastatin Calcium 20 mg to placebo 20 mg for various cardiovascular endpoints including major cardiovascular events (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization. The table includes event counts, event rates per 1000 patient years, hazard ratios with 95% confidence intervals, p values, and a forest plot of hazard ratios.*
FDA Label Image

Figure 3. (Rosuvastatin Aurobindo 4)

Figure 3. (Rosuvastatin Aurobindo 4)
A box plot chart showing percent change from baseline in LDL-C levels across different statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. Each drug is presented with multiple dose levels in milligrams (e.g., 10, 20, 40 for Rosuvastatin). The y-axis represents percent change with gridlines at -15, -30, -45, -60, and -75 percent. The chart compares the LDL-C percent reduction associated with increasing doses of each statin.*
FDA Label Image

Principal Display Panel (Rosuvastatin Aurobindo 5)

Principal Display Panel (Rosuvastatin Aurobindo 5)
Packaging label for Rosuvastatin Tablets, USP 5 mg by NCS HealthCare of KY, LLC dba Vangard Labs, manufactured by Aurobindo. The label shows the tablet dosage form with a quantity of 30 tablets per package. It includes handling instructions, lot number, barcode, and storage conditions. Multiple small labels with the same information are displayed for packaging use.*
FDA Label Image

Principal Display Panel (Rosuvastatin Aurobindo 6)

Principal Display Panel (Rosuvastatin Aurobindo 6)
Label for Rosuvastatin Tablets USP 10 mg by NCS HealthCare of KY, LLC dba Vangard Labs. The film-coated tablets are packaged in a 30 count container. The label includes lot number 8533 and indicates manufacture by Aurobindo with packaging by Vangard Labs in Glasgow, KY. The label provides storage instructions and states the product is for institutional use only.*
FDA Label Image

Principal Display Panel (Rosuvastatin Aurobindo 7)

Principal Display Panel (Rosuvastatin Aurobindo 7)
Rosuvastatin Tablets USP 20 mg film-coated oral tablets label showing packaging for institutional use only. Manufactured by Aurobindo and packaged by Vanguard Labs, Glasgow, KY. The label includes multiple individual barcode labels, storage instructions at 20° to 25°C, and a quantity of 30 tablets. Lot number 8534 is visible, along with a space for recording received dates and lot information.*
FDA Label Image

Principal Display Panel (Rosuvastatin Aurobindo 8)

Principal Display Panel (Rosuvastatin Aurobindo 8)
Rosuvastatin Calcium 40 mg film-coated tablets labeling sheet showing multiple unit dose labels arranged for institutional packaging. Labels include the drug name, strength, lot number, barcodes, and packaging information by Vanguard Labs, Glasgow, KY. The sheet also contains handling and storage instructions, dosage form, quantity 30, and manufacturer details by Aurobindo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.